Curis
CRIS
#10176
Rank
C$18.93 M
Marketcap
C$1.38
Share price
0.00%
Change (1 day)
-63.49%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.01. In 2024 the company made an earnings per share (EPS) of C-$9.60 an increase over its 2023 EPS that were of C-$12.33.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-45.82%
2024C-$9.60-22.15%
2023C-$12.33-26.17%
2022C-$16.7022.3%
2021C-$13.65-25.37%
2020C-$18.29-30.93%
2019C-$26.49-2.02%
2018C-$27.03
2016C-$61.44-10%
2015C-$68.26138.1%
2014C-$28.6740%
2013C-$20.48-25%
2012C-$27.3066.67%
2011C-$16.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.05-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.49-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$3.25-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$4.61-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.35 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.93-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA